These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2573579)

  • 21. Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis.
    Guérin M; Barrois M; Terrier MJ; Spielmann M; Riou G
    Oncogene Res; 1988; 3(1):21-31. PubMed ID: 2905033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chromosome 11q13, c-erbB-2, and c-myc amplification in invasive breast carcinoma: clinicopathologic correlations.
    Gaffey MJ; Frierson HF; Williams ME
    Mod Pathol; 1993 Nov; 6(6):654-9. PubMed ID: 7905628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amplification of c-myc and c-erbB-2 proto-oncogenes in human solid tumors: frequency and clinical significance.
    Gutman M; Ravia Y; Assaf D; Yamamoto T; Rozin R; Shiloh Y
    Int J Cancer; 1989 Nov; 44(5):802-5. PubMed ID: 2573579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amplification of cellular oncogenes: a predictor of clinical outcome in human cancer.
    Schwab M; Amler LC
    Genes Chromosomes Cancer; 1990 Jan; 1(3):181-93. PubMed ID: 1982063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oncogene amplification in tumor cells.
    Alitalo K; Schwab M
    Adv Cancer Res; 1986; 47():235-81. PubMed ID: 3022564
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical and pathologic significance of the c-erbB-2 (HER-2/neu) oncogene.
    Singleton TP; Strickler JG
    Pathol Annu; 1992; 27 Pt 1():165-90. PubMed ID: 1346551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amplification and overexpression of the erbB-2 gene in human tumors: its involvement in tumor development, significance as a prognostic factor, and potential as a target for cancer therapy.
    Hynes NE
    Semin Cancer Biol; 1993 Feb; 4(1):19-26. PubMed ID: 8095411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What's new in breast cancer? Molecular perspectives of cancer development and the role of the oncogene c-erbB-2 in prognosis and disease.
    Dawkins HJ; Robbins PD; Smith KL; Sarna M; Harvey JM; Sterrett GF; Papadimitriou JM
    Pathol Res Pract; 1993 Dec; 189(10):1233-52. PubMed ID: 7910395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Oncogenes and anti-oncogenes in breast cancer].
    Birnbaum D; Gaudray P
    Bull Cancer; 1989; 76(7):677-87. PubMed ID: 2573395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene amplification and tumor progression.
    Brison O
    Biochim Biophys Acta; 1993 May; 1155(1):25-41. PubMed ID: 8504129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The human breast carcinoma cell line SW 613-S: an experimental system to study tumor heterogeneity in relation to c-myc amplification, growth factor production and other markers (review).
    Lavialle C; Modjtahedi N; Lamonerie T; Frebourg T; Landin RM; Fossar N; Lhomond G; Cassingena R; Brison O
    Anticancer Res; 1989; 9(5):1265-79. PubMed ID: 2686529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activated oncogenes and putative tumor suppressor genes involved in human breast cancers.
    Tripathy D; Benz CC
    Cancer Treat Res; 1992; 63():15-60. PubMed ID: 1363356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The significance of oncogene amplification in primary breast cancer.
    Seshadri R; Matthews C; Dobrovic A; Horsfall DJ
    Int J Cancer; 1989 Feb; 43(2):270-2. PubMed ID: 2563720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The myc family of nuclear proto-oncogenes.
    Lee WM
    Cancer Treat Res; 1989; 47():37-71. PubMed ID: 2577005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cellular oncogenes and suppressor genes as prognostic markers in cancer.
    Duffy MJ
    Clin Biochem; 1993 Dec; 26(6):439-47. PubMed ID: 8124858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neu (C-erbB-2) oncogene in breast cancer and its possible association with the risk of distant metastases. A retrospective study and review of literature.
    Makar AP; Desmedt EJ; De Potter CR; Vanderheyden JS; Schatteman EA
    Acta Oncol; 1990; 29(7):931-4. PubMed ID: 1979748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of the oncogene c-myc in sporadic large bowel cancer and familial polyposis coli.
    Rothberg PG
    Semin Surg Oncol; 1987; 3(3):152-8. PubMed ID: 2821605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic variability of proto-oncogenes for breast cancer risk and prognosis.
    Lidereau R; Mathieu-Mahul D; Escot C; Theillet C; Champeme MH; Cole S; Mauchauffe M; Ali I; Amione J; Callahan R
    Biochimie; 1988 Jul; 70(7):951-9. PubMed ID: 2905174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular biologic investigations of proto-oncogenes and growth factors in human testicular tumors.
    Strohmeyer T
    World J Urol; 1994; 12(2):74-8. PubMed ID: 7522081
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.